Isabel Martinez Leal
Overview
Explore the profile of Isabel Martinez Leal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddiqi A, Carter B, Britton M, Chen T, Martinez Leal I, Moosa A, et al.
Healthcare (Basel)
. 2025 Feb;
13(3).
PMID: 39942527
Background/objectives: Rural populations in the US bear a disproportionate burden of cancer mortality, which may be partly due to their elevated tobacco use and the limited receipt of tobacco use...
2.
Siu K, Martinez Leal I, Heredia N, Foreman J, Hwang J
Am J Lifestyle Med
. 2025 Feb;
:15598276251319262.
PMID: 39926169
Metabolic syndrome (MetS) is associated with increased cancer risk and poor cancer prognosis. The current study applied a mixed methods approach to better understand attitudes about making lifestyle changes and...
3.
Kakarla S, Shabaneh N, Jafry M, Britton M, Rogova A, Carter B, et al.
Health Behav Policy Rev
. 2024 Nov;
11(1):1471-1482.
PMID: 39600590
Objectives: Adults with behavioral health needs exhibit elevated tobacco use rates. Tobacco-free workplace policies (TFWPs) at behavioral health treatment centers can effectively curb clients' tobacco use and secondhand smoke/vape exposure....
4.
Martinez Leal I, Pillai A, Foreman J, Siu K, Heredia N, Escalante C, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335119
Metabolic syndrome is a group of disorders-hypertension, dyslipidemia, obesity, and insulin resistance-that together increase the risk of coronary heart disease, stroke, and diabetes. Although ~60% of cancer patients have metabolic...
5.
Martinez Leal I, Siddiqi A, Rogova A, Britton M, Chen T, Williams T, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893280
Despite the high tobacco use rates (~80%) and tobacco-related cancers being the second leading cause of death among people experiencing homelessness within the United States, these individuals rarely receive tobacco...
6.
Siddiqi A, Carter B, Chen T, Martinez Leal I, Britton M, Correa-Fernandez V, et al.
Transl Behav Med
. 2024 May;
14(7):394-401.
PMID: 38757794
Tobacco-free workplace policies (TFWPs) are underused evidence-based interventions that reduce the elevated use of tobacco among substance use treatment center (SUTC) employees and patients. SUTC employees' anticipated concerns about stakeholder...
7.
Rogova A, Martinez Leal I, Britton M, Chen T, Lowenstein L, Kyburz B, et al.
BMC Health Serv Res
. 2024 Feb;
24(1):201.
PMID: 38355470
Background: People with substance use disorders smoke cigarettes at much higher rates than the general population in the United States and are disproportionately affected by tobacco-related diseases. Many substance use...
8.
Martinez Leal I, Acquati C, Rogova A, Chen T, Connors S, Agrawal P, et al.
J Health Psychol
. 2023 Nov;
29(5):367-381.
PMID: 38009435
COVID-19 has critically impacted cancer care services including reduced screenings, diagnoses, and surgeries; particularly among Black and Latina/x women who already suffer worse outcomes. This qualitative study explored the care...
9.
Britton M, Rogova A, Chen T, Martinez Leal I, Kyburz B, Williams T, et al.
Prev Med Rep
. 2023 Sep;
35:102256.
PMID: 37752980
Patients with behavioral health conditions have disproportionately high tobacco use rates and face significant barriers to accessing evidence-based tobacco cessation services. Tobacco quitlines are an effective and accessible resource, yet...
10.
Martinez Leal I, Pillai A, Foreman J, Siu K, Heredia N, Escalante C, et al.
Res Sq
. 2023 Sep;
PMID: 37720029
Background: Nearly 60% of patients with cancer have metabolic syndrome, which increases the risk of mortality, but there is no clear guidance for oncology providers about its management. Here, we...